Blog

Valproate prescriptions for men with epilepsy are now subject to precautionary measures across the European Union (EU), as announced by the European Medicines Agency (EMA). These measures align with the guidelines set by the UK's Medicines and Healthcare products Regulatory Agency (MHRA) but are comparatively less stringent. In the UK, individuals under the age of…

Category: News

Living with epilepsy involves navigating a complex landscape of treatments and strategies to enhance overall well-being. In recent years, innovative approaches have emerged to complement traditional therapies. One such promising frontier is Virtual Reality (VR) therapy, offering new possibilities for managing epilepsy and improving the quality of life for individuals dealing with this neurological condition.…

Category: Living with Epilepsy, News

Epilepsy is extremely complex with a diverse range of causes and manifestations. While some cases of epilepsy are linked to identifiable factors, others appear to have a genetic basis. Genetic testing has emerged as a valuable tool in understanding the genetic underpinnings of epilepsy, providing insights into diagnosis, treatment options, and personalised care. In this…

Category: Living with Epilepsy, News

In the realm of epilepsy, the management of new-onset refractory status epilepticus (NORSE) poses unique challenges. However, a promising avenue of research has emerged, focusing on the potential of Vagus Nerve Stimulation (VNS) as a novel treatment option. This blog post delves into recent research that investigates the application of VNS in NORSE, shedding light…

Category: News, Treatments

The National Health Service (NHS) in the UK has recently announced that it will be offering a new form of laser surgery for epilepsy patients. The procedure, called epilepsy laser ablation, uses laser technology to destroy abnormal brain tissue that causes seizures. This is a newer, more advanced version of a traditional surgical procedure called…

Category: News

A study into how cost effective it could be to implement new EEG technology on the NHS has been launched. The study will recruit 33 people with medication resistant epilepsy to trial the small EEG device over a six month period.  The technology itself, which has been developed by Danish company UNEEG medical, is a…

Category: News